CPG
ALNY icon

Cornerstone Planning Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cornerstone Planning Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.1K Buy
100
+5
+5% +$1.7K ﹤0.01% 542
2025
Q4 		$33.2K Sell
95
-397
-81% -$176K 0.01% 443
2025
Q3 		$56.2K Buy
492
+450
+1,071% +$183K 0.01% 314
2025
Q2 		$17.6K Buy
42
+8
+24% +$2.21K ﹤0.01% 446
2025
Q1 		$8.23K Buy
34
+11
+48% +$2.83K ﹤0.01% 620
2024
Q4 		$6.37K Hold
23
– – ﹤0.01% 530
2024
Q3 		$6.55K Buy
23
+10
+77% +$2.6K ﹤0.01% 511
2024
Q2 		$3.44K Buy
+13
New +$2.05K ﹤0.01% 650
2024
Q1 		– Sell
-1
Closed -$191 – 1109
2023
Q4 		$191 Hold
1
– – ﹤0.01% 865
2023
Q3 		$177 Buy
+1
New +$191 ﹤0.01% 1040

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return